Epic Research
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss The digital health platforms new GLP-1 Rx program pairs microdosed weight-loss drugs with biomarker testing and behavior change to target early metabolic risk For consumers intrigued by the promise of GLP-1 medications but who dont meet the BMI requirements typically tied to prescriptions, the door has largely stayed closed until now
Freezing temperatures damage the molecular structure of the peptide and render it ineffective, so never place semaglutide in the freezer, even briefly during transport
Walking, Tai chi, and targeted strength exercises are all appropriate tools
BI 456906 (survodutide), developed as a dual agonist for GLP-1 and glucagon receptors for the treatment of obesity and NASH, is structurally modified from glucagon [109]
The magnitude of GLP-1 increase is actually larger with surgery than with drug therapy, Azagury said